Literature DB >> 21800144

Hepatitis C virus and lipid profiles: more questions than answers?

Ching-Sheng Hsu1,2, Jia-Horng Kao3,4,5,6.   

Abstract

Entities:  

Keywords:  Apolipoprotein C-III; Fibrosis; Hepatitis C virus; Pegylated interferon

Year:  2011        PMID： 21800144     DOI： 10.1007/s12072-011-9298-3

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  27 in total

Review 1.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

2.  Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

Authors:  Gioacchino Leandro; Alessandra Mangia; Jason Hui; Paolo Fabris; Laura Rubbia-Brandt; Guido Colloredo; Luigi E Adinolfi; Tarik Asselah; Julie R Jonsson; Antonina Smedile; Norah Terrault; Valerio Pazienza; Maria Teresa Giordani; Emiliano Giostra; Aurelio Sonzogni; Giuseppe Ruggiero; Patrick Marcellin; Elizabeth E Powell; Jacob George; Francesco Negro
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

3.  Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.

Authors:  Silvia Mirandola; Stefano Realdon; Jahangir Iqbal; Martina Gerotto; Francesca Dal Pero; Gladis Bortoletto; Moira Marcolongo; Alessandro Vario; Christian Datz; M Mahmood Hussain; Alfredo Alberti
Journal:  Gastroenterology       Date:  2006-03-06       Impact factor: 22.682

Review 4.  Transmission of hepatitis C virus in Asia: past and present perspectives.

Authors:  J H Kao; D S Chen
Journal:  J Gastroenterol Hepatol       Date:  2000-05       Impact factor: 4.029

Review 5.  Epidemic obesity and type 2 diabetes in Asia.

Authors:  Kun-Ho Yoon; Jin-Hee Lee; Ji-Won Kim; Jae Hyoung Cho; Yoon-Hee Choi; Seung-Hyun Ko; Paul Zimmet; Ho-Young Son
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

6.  Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids.

Authors:  Sharookh B Kapadia; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

7.  Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin.

Authors:  Manuel Romero-Gómez; Moisés Diago; Raúl J Andrade; José L Calleja; Javier Salmerón; Conrado M Fernández-Rodríguez; Ricard Solà; Javier García-Samaniego; Juan M Herrerías; Manuel De la Mata; Ricardo Moreno-Otero; Oscar Nuñez; Antonio Olveira; Santiago Durán; Ramón Planas
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

8.  Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.

Authors:  Ching-Sheng Hsu; Chen-Hua Liu; Chun-Jen Liu; Chia-Chi Wang; Chi-Ling Chen; Ming-Yang Lai; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Am J Gastroenterol       Date:  2009-02-10       Impact factor: 10.864

Review 9.  Treatment of chronic hepatitis C in Asia: when East meets West.

Authors:  Ming-Lung Yu; Wan-Long Chuang
Journal:  J Gastroenterol Hepatol       Date:  2009-03       Impact factor: 4.029

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.